“…mRNA in RA > OA or non arthritic joints, at synovial lining, sites of attachment and invasion into cartilage or bone, around small vessels and in areas of infiltrating lymphocytes (fibroblasts not macrophages or T cells) yes (Seibl et al, 2003) Protein in RA > OA or healthy joints in synovial lining, sublining and perivascular regions nd Protein in RA blood monocytes, tissue macrophages yes (Iwahashi et al, 2004;Huang et al, 2007) Protein in fibroblasts from RA > OA joints > healthy skin yes TLR3 mRNA and protein in RA > OA or healthy synovium, in fibroblasts of the synovial lining and sublining, and in the perivascular areas yes (Brentano et al, 2005;Roelofs et al, 2005) Protein in fibroblasts from early RA > OA or healthy synovium yes (Ospelt et al, 2008) TLR4 mRNA in RA synovial tissue, protein in DCs and macrophages but not T cells or fibroblasts from RA joint yes ) (Tamaki et al, 2011) (Huang et al, 2007) Protein in synovial tissue from RA > OA > healthy joints, in early and longstanding RA yes ) (Ospelt et al, 2008) Protein in RA synovial fibroblasts yes Wu et al, 2010) TLR5 Protein in DCs> macrophages > fibroblasts from RA joint nd (Tamaki et al, 2011) TLR6 Protein in DCs> macrophages > fibroblasts from RA joint nd (Tamaki et al, 2011) TLR7 Protein in RA synovium > OA or healthy joints yes (Roelofs et al, 2005;Roelofs et al, 2009) TLR9 Protein in DCs> macrophages > fibroblasts from RA joint nd (Tamaki et al, 2011) nd = not determined F= function = the ability of the TLR to respond to its cognate ligand in each cell/tissue type Further studies using ex vivo human disease models have provided evidence of a functional role for TLRs in driving inflammation in RA. Adenoviral over expression of dominant negative Myd88, an adaptor molecule required for signalling by all TLRs except TLR3, inhibited cytokine synthesis in RA synovial cells .…”